All eyes may be on rising drug costs, but that doesn't mean pharma companies are backing away from price hikes. In recent days, analysts have spotlighted hundreds of increases, more than 100 of them at Pfizer ($PFE) alone, that took effect January 1.
And now, the market researchers at Truveris have another update: Branded prescription drug prices went up 14.5% last year overall. Pricey specialty drugs went up by 9.2%. The company's price index covers private insurers, self-insured groups, government programs and uninsured patients.
The increases were on par with those seen in 2014, Truveris says, showing that the price hikes highlighted last year weren't isolated occurrences. In fact, 2015 was the third year in a row with double-digit price increases.